SCHEMBL13173972

SCHEMBL13173972

Cc1cccc(C(=O)Nc2cc(-c3nc4ccccc4s3)ccc2C)c1

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.78
▸ POLB P06746 3/20 0.73
▸ TP53 P04637 6/20 0.71
▸ ALDH1A1 P00352 3/20 0.69
▸ NPSR1 Q6W5P4 2/20 0.69
▸ KDM4E B2RXH2 2/20 0.69
▸ HPGD P15428 1/20 0.69
▸ MEN1 O00255 4/20 0.68
▸ KMT2A Q03164 4/20 0.68
▸ CYP3A4 P08684 3/20 0.68
▸ CYP2C9 P11712 3/20 0.68
▸ CYP1A2 P05177 2/20 0.68
▸ CYP2C19 P33261 2/20 0.68
▸ SCD O00767 1/20 0.64
▸ SMN1; SMN2 Q16637 4/20 0.60
▸ LMNA P02545 2/20 0.60
▸ RXFP1 Q9HBX9 3/20 0.60
▸ PTPN7 P35236 1/20 0.58
▸ DUSP3 P51452 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12963192 0.91 TP53 (0.69) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL24711450 0.90 MAPT (0.69) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL16774973 0.86 MAPT (0.77) MAPTTP53ALDH1A1KDM4EHPGD
SCHEMBL12963202 0.85 TP53 (0.71) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL12963468 0.85 MAPT (0.76) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL12963175 0.85 MAPT (0.75) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL12963241 0.84 MAPT (0.67) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL24710841 0.84 MAPT (0.72) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL16602324 0.84 TP53 (0.75) MAPTPOLBTP53ALDH1A1NPSR1
SCHEMBL12963196 0.83 MAPT (0.78) MAPTPOLBTP53ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993604-B2 Treatment and prevention of dengue virus infections SIGA TECHNOLOGIES, INC. (US) 2015-03-31 — — US disclosed
US-8993604-B2 Treatment and prevention of dengue virus infections SIGA TECHNOLOGIES, INC. (US) 2015-03-31 — — US disclosed
US-20120258079-A1 Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. 2012-10-11 — — US disclosed
US-20120258079-A1 Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. 2012-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258079-A1 Treatment and Prevention of Dengue Virus Infections HAVCR2, TTPA, CHIA MAPT 118/4885POLB 4481/4885TP53 2739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback